AZD7442 Archives -

AstraZeneca’s antibody cocktail for COVID-19, now called Evusheld, has become the first drug in the class to be

AZ’s antibody first to be cleared by FDA for COVID prevention

https://pharmaphorum.com/news/azs-antibody-first-to-be-cleared-by-fda-for-covid-prevention/

As expected, Merck & Co has moved ahead swiftly with an emergency use application for its oral antiviral

Merck files pill for milder COVID, as AZ showcases its antibody data

https://pharmaphorum.com/news/merck-files-pill-for-milder-covid-as-az-showcases-its-antibody-data/

AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent

AZ files for emergency use of COVID-19 antibody combo in US

https://pharmaphorum.com/news/az-files-for-emergency-use-of-covid-antibody-combo-in-us/

AstraZeneca’s AZD7442 has shown that it can prevent COVID-19 infection when given to healthy patients – the first

PROVENT trial puts AZ COVID antibody combo back on track

https://pharmaphorum.com/news/provent-trial-puts-az-covid-antibody-combo-back-on-track/

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that

Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail

https://pharmaphorum.com/news/chasing-regeneron-az-starts-trials-of-its-covid-19-antibody-cocktail/

AZD7442